Human Anti-Influenza virus B IgA ELISA Kit
Be the first to review this product! Submit a review
|
(2 Publications)
- Colorimetric readout - 450 nm - Works on any standard plate reader
- Easy results interpretation
- Cut-off, positive and negative controls included
Reactivity data
Product details
Abcam's anti-Influenza virus B IgA Human in vitro ELISA (Enzyme-Linked Immunosorbent Assay) kit is designed for the accurate qualitative measurement of IgA class antibodies against Influenza virus B in Human serum and plasma.
A 96-well plate has been precoated with Influenza virus B antigens to bind cognate antibodies. Controls or test samples are added to the wells and incubated. Following washing, a horseradish peroxidase (HRP) labelled anti-Human IgA conjugate is added to the wells, which binds to the immobilized Influenza virus B-specific antibodies. TMB is then catalyzed by the HRP to produce a blue color product that changes to yellow after adding an acidic stop solution. The density of yellow coloration is directly proportional to the amount of Influenza virus B IgA sample captured in plate.
Precision
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Immunoglobulin A functions in the immune surveillance of mucosal membranes. This target belongs to the immunoglobulin complex an essential part of the adaptive immune system. It neutralizes pathogens by binding to them preventing attachment and entry into host cells. IgA specifically in the form of secretory IgA contributes to the first line of defense against respiratory infections including influenza virus.
Pathways
IgA is a critical component in the mucosal immune response pathway. It interacts with other proteins such as the polymeric immunoglobulin receptor (pIgR) which facilitates its transport across epithelial cells. Additionally it connects to the complement pathway activating the antibody-dependent cell-mediated cytotoxicity (ADCC) working synergistically with other immunoglobulins and complement proteins to enhance pathogen clearance.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in nutrition 10:1116634 PubMed37168053
2023
Applications
Unspecified application
Species
Unspecified reactive species
Vaccines 10: PubMed35891309
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com